Home » Topics » Science » Drug design, drug delivery and technologies

Drug design, drug delivery and technologies
RSS

OSI receives patent protection for its gene transcription-regulating drugs

July 20, 1998

Trega identifies lead compounds in R&D collaboration with Ono

July 17, 1998

Bioject enters vaccine delivery agreement with Merck

July 17, 1998

Nexell's Isolex technology receives U.S. patent protection; FDA requests more data

July 16, 1998

Cyclacel licenses novel drug delivery technology from CNRS

July 15, 1998

MacroChem and American Home Products sign collaborative agreement

July 13, 1998

Iomed and Novartis to discontinue research collaboration

July 9, 1998

Sheffield and Elan finalize pulmonary drug delivery collaboration

July 9, 1998

Oxford Molecular Group enters research collaboration with Mitsubishi Chemical

July 6, 1998

Abgenix and Genentech expand collaboration

July 2, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 24, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 24, 2025.
Researchers discover how glioblastoma tumors dodge chemotherapy
BioWorld MedTech
Researchers at the University of Sydney have uncovered a mechanism that may explain why glioblastoma returns after treatment, and the world-first discovery offers...
HIV research is close to a cure but far from ending the pandemic
BioWorld
Advances in antiretroviral therapy (ART) now allow people living with HIV to lead normal lives with undetectable and nontransmissible levels of the virus in their...
ADEL wins $1.04B Sanofi deal for tau-targeting Alzheimer’s drug
BioWorld
ADEL Inc. closed a year-end licensing deal worth up to $1.04 billion with Sanofi SA for ADEL-Y01, a specific tau-targeting Alzheimer’s disease drug candidate in a...